Similar drugsTo uncover
Dosage form: & nbspinjection
Composition:

The ampoule contains one prophylactic dose - 30,000 international units (ME) of anti-gangrene antitoxin activity: FROMl, perfringens - 10000 ME, Cl. oedematiens - 10000 ME, Cl. septicum - 10000 ME.

Description:

Serum antiangentric polyvalent horse purified concentrated PIt is a clear or slightly opalescent colorless or yellowish tinged liquid, without sediment.

Available in the kit with serum equine diluted 1: 100, which is a clear, colorless liquid, without sediment.

Pharmacotherapeutic group:MIBP - serum
ATX: & nbsp
  • Anti-gangrenous serum
  • Pharmacodynamics:

    The drug is a protein fraction of blood serum of horses, hyperimmunized with anatoxins or toxins of gas gangrene (Clostridium perfringens type A, Cl.oedematiens type A, Cl. septicum), purified and concentrated by peptic digestion and salt fractionation, containing specific toxin neutralizing antibodies.

    Biological properties

    Antibodies contained in the preparation neutralize the toxins of anaerobic microbes Cl.perfringens type A, Cl.oedematiens type A, Cl.septicum.
    Indications:

    Treatment and prevention of gas gangrene.

    Contraindications:

    Contraindications for the use of serum anti-gangrene are absent.

    Pregnancy and lactation:

    The use of the drug is allowed for life indications, taking into account the possible benefits for the mother and the risk of fetal or child.

    Dosing and Administration:

    For preventive purposes Serum is injected intramuscularly as soon as possible after injury.

    With a curative purpose serum is administered intravenously, very slowly, by drop method, usually in a mixture with a solution for injection of 0.9%, heated to the body temperature of sodium chloride, at the rate of 100-400 ml per 100 ml of serum.

    Serum is heated to (36 ± 0.5) ° C and injected: first 1 ml for 5 minutes, then 1 ml per minute.

    Serum is administered by a doctor, or under his supervision.

    The amount of serum administered depends on the clinical condition of the patient.

    Usually therapeutic dose serum antigangrenous is 150 thousand. ME:

    - antiphrinter - 50,000 ME,

    - anti-epidemiants - 50000 ME,

    - antiseptic - 50,000 ME.

    Before the introduction of serum anti-gangrenous, an intradermal test with a horse serum of diluted 1: 100 diluted (ampoule marked in red) is mandatory to check the sensitivity of the patient to horse serum proteins.

    Serum horse purified diluted 1: 100 is injected in a volume of 0.1 ml intradermally into the flexor surface of the forearm (use syringes with a fission rate of 0.1 ml and thin needles).

    The reaction is taken into account after 20 minutes. The sample is considered negative if the diameter of the edema and (or) redness appearing at the injection site is less than 1 cm. The sample is considered positive if the edema and (or) redness reaches a diameter of 1 cm or more.

    With negative intracutaneous sample, serum anti-gangrenous (ampoule is marked in blue) is administered subcutaneously in an amount of 0.1 ml. In the absence of reaction after 30 minutes, the entire prescribed dose of serum is administered intramuscularly (for prophylactic purposes) or intravenously (for therapeutic purposes).

    With a positive intradermal test, serum is administered only on unconditional indications under the supervision of a doctor and with special precautions. Initially, injected under the skin serum anti-gangrene, diluted in doses of 0.5 ml, 2.0 ml, 5.0 ml (diluted serum is prepared immediately before use, introducing 0.1 ml of serum antigangrenous in 9.9 ml of sodium chloride solution for injection 0 , 9%) with an interval of 20 minutes.In the absence of reaction to these doses, 0.1 ml serum antigangrenous is injected subcutaneously. In the absence of reaction after 30 minutes, all the prescribed amount of serum is administered intramuscularly (for prophylactic purposes) or intravenously (for therapeutic purposes). In the case of a positive reaction to one of the above doses, serum anti-gangrene is not injected or injected under anesthesia, having a syringe ready with a 0.1% solution of epinephrine hydrochloride or a 0.2% solution of noradrenaline hydrotartrate.

    All manipulations are performed by separate sterile syringes. Opened ampoule with serum anti-gangrene, close with a sterile tissue, stored at a temperature (20 + 2) ° C not more than 1 hour. An uncovered ampoule with an equine serum diluted 1: 100 is not subject to storage.

    Side effects:

    The introduction of serum can lead to the development of anaphylactic shock and other allergic reactions of immediate type, as well as the symptomatic complex of serum sickness (fever, skin rashes, arthralgia) that appears in the early (2-6) days and distant (at 2 weeks), duration from several hours to several weeks.

    Overdose:
    Not installed.
    Interaction:Not identified.
    Special instructions:

    Given the possibility of shock when serum is administered anti-gangrene, it is necessary to provide medical supervision for each vaccine within 1 hour after the administration of the drug. Vaccination sites should be provided with anti-shock therapy.

    Persons who received serum anti-gangrene should be warned about the need to seek immediate medical attention in case of signs characteristic of serum sickness.

    The drug is not suitable for use in ampoules with broken integrity or missing marking, with a change in physical properties (color, transparency, presence of non-flocculating flakes), expired, with improper storage.

    Effect on the ability to drive transp. cf. and fur:None.
    Form release / dosage:Injection, 30 000 ME.
    Packaging:

    Serum antiangroneous polyvalent horse purified concentrated, injection - to 30000 ME in ampoules (10,000 each ME of each antitoxin).

    Horse serum, diluted 1: 100 diluted, solution for intradermal administration - 1 ml in ampoules.

    1 set (1 ampoule of serum anti-gangrene (ampoule is marked in blue) and 1 ampoule of horse serum diluted 1: 100 (ampoule is marked in red)) in a plastic liner together with instruction for use and scarifier ampoule in a pack of cardboard.

    When using ampoules with notches, a ring of fracture or a point for opening, the ampoule scaper is not inserted.

    Storage conditions:

    Conditions of transportation. In accordance with SP 3.3.2.1248-03 at a temperature of 2 to 8 ° C. Freezing is not allowed.

    Storage conditions. In accordance with SP 3.3.2.1248-03 at a temperature of 2 to 8 ° C, out of reach of children. Freezing is not allowed.

    Shelf life:

    2 years.

    The drug with expired shelf life is not subject to application.

    Terms of leave from pharmacies:For hospitals
    Registration number:LS-001035
    Date of registration:30.12.2011 / 19.04.2013
    The owner of the registration certificate:MICROGEN FGUP Scientific and Production Association MICROGEN FGUP Scientific and Production Association Russia
    Manufacturer: & nbsp
    Representation: & nbspMICROGEN FGUP Scientific and Production Association MICROGEN FGUP Scientific and Production Association Russia
    Information update date: & nbsp13.03.2016
    Illustrated instructions
      Instructions
      Up